Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation

Clinical trial NCT00238901 · COMPLETED

Trial details

NCT number: NCT00238901
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Liver Transplant

Start date: 2002-12-01
Primary completion: 2005-07-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.